The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes

A. Mari, W.M. Sallas, Y.L. He, C. Watson, M. Ligueros-Saylan, B.E. Dunning, Carolyn F. Deacon, Jens Juul Holst, J.E. Foley

Research output: Contribution to journalJournal articleResearch

357 Citations (Scopus)
Original languageEnglish
JournalJournal of Clinical Endocrinology and Metabolism
Issue number90
Pages (from-to)4888-4894
ISSN0021-972X
Publication statusPublished - 2005

Cite this